Why is "R-Pharm" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-08-21 16:45:31
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
R-Pharm entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-08-21 and was most recently seen on 2026-08-21.
Wikipedia Overview
R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
R-Pharm begins final-stage trial of ocrelizumab biosimilar for multiple sclerosis - Новости GxP
-
Alexey Repik - Forbes
-
R-Pharm’s Biosimilar Pertuzumab Approved in Russia - Pearce IP
-
R-Pharm receives marketing authorization for Pertuzumab biosimilar - Новости GxP
-
R-Pharm’s Biosimilar Cetuximab Approved in Russia - Pearce IP
-
Russian drugmaker R-Pharm searching buyers for its flagship factory in Germany - The Pharma Letter
-
Russia’s R-Pharm To Invest US$200 Million Into Kazakh Pharmaceutical Factory - russia's pivot to asia
-
Moscow-based pharma firm sues Raiffeisenbank for 337.5 million euros - Reuters
-
R-Pharm’s olokizumab enters international rheumatoid arthritis guidelines for first time - Новости GxP
-
R-Pharm to bring oncology drug catequentinib to Russian market - Новости GxP
-
R-Pharm developing three drugs for cancer treatment - Новости GxP
-
R-Pharm to localise production of novel cancer drug toripalimab in Russia - Новости GxP
-
Russia’s R-Pharm develops novel antibodies for cancer therapy - Новости GxP
-
R-Pharm expands its portfolio of proprietary anti-tumor drugs - Новости GxP
-
Russian drugmaker R-Pharm to study goflicicept and olokizumab in Still’s disease patients - Новости GxP
-
Production of Chinese medical equipment may be localized in Russia - Новости GxP
-
Export: What Russian Pharma Offers the World Drug Market - Новости GxP
-
Goflikicept demonstrated efficacy in Familial Mediterranean Fever - Новости GxP
-
R-Pharm presents new data on olokizumab and goflicept at the APLAR Congress in Japan - Новости GxP
-
Moscow plant launches aseptic production of cancer drugs - Новости GxP
-
What government support mechanisms are available for the pharma industry today - Новости GxP
-
AstraZeneca confirms Russia vaccine deal days after COVID-19 hacking accusations surface - Fierce Pharma
-
R-Pharm has launched the new medication “Arcerix” for commercial distribution - Новости GxP
-
Christopher Finch Appointed Dean of the R. Ken Coit College of Pharmacy - University of Arizona Provost
-
Russia's R-Pharm signs deal to make UK-developed COVID-19 vaccine - Reuters
-
R-Pharm’s drug receives orphan status in Saudi Arabia - Новости GxP
-
R-Pharm has been authorized to conduct research on the Munjaro generic - Новости GxP
-
R-Pharm has registered Russia’s first generic drug for viral hepatitis C - Новости GxP
-
R-Pharm presents data on Olokizumab at International Congress in Singapore - Новости GxP
-
Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm | 2017 | Releases - mitsui.com
-
R-Pharm Group localized the production of Dr. Reddy’s rituximab - Новости GxP
-
Bavaria freezes Sputnik V production in Germany citing sanctions against Russia - Reuters
-
R-Pharm reported phase III trial results of pembrolizumab - Новости GxP
-
Illumina and R-Pharm receive device registration for sequencing platforms - Medical Device Network
-
Russia’s R-Pharm Group eyes expansion in Southeast Asia - The Pharma Letter
-
R-Pharm Publishes New Results on Olokizumab in European Journal - Новости GxP
-
Russia authorises first Covid-19 drug Coronavir for sale in pharmacies - Pharmaceutical Technology
-
Olokizumab data was presented by R-Pharm at a congress in Thailand - Новости GxP
-
Vasily Ignatiev took part in the XX Congress of Delovaya Rossiya (Business Russia) with the participation of President Vladimir Putin - Новости GxP
-
Pearce IP BioBlast® for the last three weeks ending 9 January 2026 - Pearce IP
-
Gout Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - InventisBio, Allena, Olatec, Shanton, LG Chem, Arthrosi, Jiangsu Hengrui Medicine, AstraZeneca, R-Pharm, Arrowhead, Horizon - PR Newswire
-
R-Pharm to produce AstraZeneca vaccine in Russia - The Pharma Letter
-
Chief Pharmacy Officer Jason R. Smith on the Challenges Health Systems Face - Managed Healthcare Executive
-
Russian oligarch profits from occupation of Ukraine while maintaining US ties – media - Euromaidan Press
-
The R-Pharm plant in Azerbaijan will start producing medicines in 2021 - Новости GxP
-
R-Pharm has become the most frequently mentioned company in the media among private Russian pharmaceutical businesses - Новости GxP
-
Janssen and R-Pharm to compete for $45 million contract in Russia - The Pharma Letter
-
R-Pharm finished the purchasing of the Yaroslavl Teva plant - Новости GxP
-
Sechenov University, in collaboration with R-Pharm, is pioneering an innovative master’s program - Новости GxP
-
“The “Artlegia” drug has been officially registered in Belarus by R-Pharm - Новости GxP
-
Meeting on the signing of a memorandum between the Gamaleya Centre, AstraZeneca, RDIF and R-Pharm - Президент России
-
Inside Mariupol: Russia’s new Potemkin village - Financial Times
-
R-Pharm sent 25 thousand packages of Artlegia to the regions as part of free assistance - Новости GxP
-
SK chemicals, Kyungnam Pharm team up to boost OTC allergic rhinitis sales - Korea Biomedical Review
-
Competition in Russian market for anti-HIV drugs - The Pharma Letter
-
First Approval of Diagnostic NGS Platforms in Russia - Clinical Lab Products
-
R-Pharm has successfully registered the anti-tuberculosis drug Deltiba in Belarus - Новости GxP
-
Goflikicept from R-Pharm has been registered in Russia - Новости GxP
-
Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase III Study - BioSpace
-
The Ortat plant is set to open a laboratory complex in Kostroma - Новости GxP
-
A new investment project has been launched at Ortat pharmaceutical plant - Новости GxP
-
Russian drugmakers put pressure on Roche cancer therapies in domestic market - The Pharma Letter
-
New sanctions target Putin’s war machine and financial networks as UK accelerates economic pressure on Russia - GOV.UK
-
Ray accelerators of the R-Pharm Group of Companies have received the status of a domestic product - Новости GxP
-
Biocad has filed a complaint against the results of consideration of applications for the conclusion of an offset contract - Новости GxP
-
Russia and China To Integrate Healthcare Medical Standards - russia's pivot to asia
-
The founder of Promomed has become a new billionaire - Новости GxP
-
Third Mounjaro analogue registered in Russia - Новости GxP
-
Tenth generic of thrombopoietin drug Revolade to enter Russian market - Новости GxP
-
Pulse took first place in Russian pharmaceutical distributors ranking - Новости GxP
-
TR PHARM OFFICE - Architect Magazine
-
Scanner Project reveals oligarch Alexei Repik as real estate developer in occupied Mariupol and business owner in the US and Germany - theins.press
-
Russia, Explained#53. Shady Covid drugs — Silencing Covid whistleblowers — Yanukovych eyes Crimea - Новая газета
-
Thailand: OIC looks to Russia for data-driven insurance supervision - Asia Insurance Review
-
The Azerbaijani pharmaceutical plant "R-PHARM" has signed an agreement with the Russian company Gerof - Baku.ws
-
BHOS embarks on cooperation with famous Russian R-Pharm company - Azərtac
-
Rushin’ to get the Russian vaccine? EMA starts review of Sputnik V drug - Extra.ie
-
Azerbaijan to commence insulin production in 2025 - Report.az
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.